* Data collected
08/23/09 - 08/30/09 |
|
|
|
| Investor Relations > Analyst Coverage| Firm | Analyst | Phone | | Banc of America Securities | Robert M. Willoughby | 212-847-5665 | | Barclays Capital | Adam Feinstein | 212-526-5496 | | Citi | Gary Taylor | 212-816-0975 | | Credit Suisse | Ralph Giacobbe | 212-538-5691 | | Deutsche Bank | Darren Lehrich | 212-250-2629 | | Goldman Sachs & Co. | Matthew Borsch | 212-902-6784 | | Jefferies & Co. | Arthur I. Henderson | 615-963-8341 | | Leerink Swann | Jason Gurda | 212-277-6023 | | Maxim Group | Anthony Vendetti | 212-895-3802 | | Oppenheimer & Co. Inc. | Charles Rhyee | 212-667-5518 | | Piper Jaffray | William B. Quirk | 612-303-6858 | | RBC Capital Markets | Kevin Ellich | 612-313-1247 | | Suntrust Robinson Humphrey | David MacDonald | 617-345-6534 | | William Blair & Company, L.L.C. | Amanda Murphy | 312-364-8951 |
|
 |
|
| YR Ending | Q1 Mar | Q2 Jun | Q3 Sep | Q4 Dec | FISC YR Annual | NUM Brokers (FISC) | CAL YR Annual | NUM Brokers (CAL) | | 2011 | | | | | 4.63 | 8 | 4.63 | 8 | | 2010 | 0.97 | 1.08 | 1.08 | 1.06 | 4.18 | 15 | 4.18 | 15 | | 2009 | 0.89A | 1.00A | 1.02A | 0.96 | 3.84 | 6 | 3.84 | 6 | | 2008 | 0.72A | 0.83A | 0.84A | 0.87A | 3.27 | 9 | 3.27 | 9 | | 2007 | 0.59A | 0.73A | 0.77A | 0.79A | 2.88 | 13 | 2.88 | 11 | | 2006 | 0.80A | 0.82A | 0.82A | 0.77A | 3.16 | 10 | 3.16 | 10 | | 2005 | 0.64A | 0.72A | 0.66A | 0.64A | 2.63 | 11 | 2.63 | 11 | | 2004 | 0.55A | 0.64A | 0.63A | 0.60A | 2.42 | 13 | 2.42 | 12 | | 2003 | 0.43A | 0.56A | 0.56A | 0.51A | 2.06 | 14 | 2.06 | 14 |
|
Quest Diagnostics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Quest Diagnostics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Quest Diagnostics or its management. Quest Diagnostics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. |
